PAR PHARMACEUTICAL COMPANIES, INC. - FORM 10-K - EX-32.1 - CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER - February 24, 2011

Attached files

file filename
EX-32.2 - CERTIFICATION BY THE CHIEF FINANCIAL OFFICER - PAR PHARMACEUTICAL COMPANIES, INC.exhibit32cfo.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - PAR PHARMACEUTICAL COMPANIES, INC.exhibit31cfocert.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - PAR PHARMACEUTICAL COMPANIES, INC.exhibit31ceocert.htm
EX-10.7.15 - SEPARATION AGREEMENT AND RELEASE - PAR PHARMACEUTICAL COMPANIES, INC.exh10715macpheeseparationand.htm
EX-14 - CODE OF ETHICS - PAR PHARMACEUTICAL COMPANIES, INC.exh14codeofethicsupdatedjuly.htm
EX-10.5.13 - TERMS OF RESTRICTED SHARES AWARD - PAR PHARMACEUTICAL COMPANIES, INC.exh10513termsofrestrictedsha.htm
EX-21 - LIST OF SUBSIDIARIES - PAR PHARMACEUTICAL COMPANIES, INC.exhibit21listofsubsidiariesa.htm
EX-23 - CONSENT OF DELOITTE & TOUCHE, LLP - PAR PHARMACEUTICAL COMPANIES, INC.exhibit23finalconsentofindep.htm
EX-10.5.15 - TERMS OF RESTRICTED STOCK UNIT AWARD - PAR PHARMACEUTICAL COMPANIES, INC.exh10515termsofrestrictedsto.htm
EX-10.5.14 - TERMS OF STOCK OPTION - PAR PHARMACEUTICAL COMPANIES, INC.exh10514termsofstockoption20.htm
EX-10.5.12 - TERMS OF CHIEF EXECUTIVE OFFICER RESTRICTED STOCK UNIT AWARD - PAR PHARMACEUTICAL COMPANIES, INC.exh10512ceorestrictedstockun.htm
10-K - FORM 10K - PAR PHARMACEUTICAL COMPANIES, INC.f201010k22411.htm

Exhibit  32.1






CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report on Form 10-K of Par Pharmaceutical Companies, Inc. (the “Company”) for the annual period ended December 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Patrick G. LePore, Chairman, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:


(1)   The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and


(2)   The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


This certification accompanies the Report and shall not be deemed filed with the Securities and Exchange Commission and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933 or Securities Exchange Act of 1934 (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.




/s/ Patrick G. LePore

Patrick G. LePore

Chairman, President and Chief Executive Officer

February 24, 2011



Stock widget

Investing forum

PAR PHARMACEUTICAL COMPANIES, INC. Reports

Also read